This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Pediatric Ophthalmology  • Retinal/ Chorioretinal Disorders  • Pediatrics  • Neonatology and Infant Care  • Alert me on articles by topic

The Promise of New Approaches

Arch Ophthalmol. 2006;124:1775-1776.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Timely recognition and treatment of retinopathy of prematurity (ROP) is the cornerstone to improving chances for preserving vision in premature infants. The window of time when treatment must be offered is short, sometimes lasting only a few days, but the window is often predictable. Onset and evolution of ROP is timed more to the gestational age than the chronological age of premature infants. The median age when infants could develop stage 3 disease, for example, is 36.6 weeks.¹

With this in mind, it might seem that ROP screening and detection would be simple. Nothing could be further from the truth. To begin, advanced ROP can occur in a distribution of time extending from as early as 31 weeks’ gestational age to as late as many weeks after the expected due date (40 weeks). Then there is the problem of infants who are back-transferred to nurseries that are less familiar with . . . [Full Text of this Article]

AUTHOR INFORMATION
William V. Good, MD

RELATED ARTICLE

Longitudinal Postnatal Weight and Insulin-like Growth Factor I Measurements in the Prediction of Retinopathy of Prematurity
Chatarina Löfqvist, Eva Andersson, Jon Sigurdsson, Eva Engström, Anna-Lena Hård, Aimon Niklasson, Lois E. H. Smith, and Ann Hellström
Arch Ophthalmol. 2006;124(12):1711-1718.
ABSTRACT | FULL TEXT